Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 1, pp. 72-85
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 2, 2016
- Revision received September 28, 2016
- Accepted September 28, 2016
- Published first September 30, 2016.
Article Versions
- Previous version (September 30, 2016 - 06:12).
- Previous version (December 19, 2016 - 06:38).
- You are viewing the most recent version of this article.
Copyright & Usage
©2016 American Association for Cancer Research.
Author Information
- Nikolaos Svoronos1,
- Alfredo Perales-Puchalt1,
- Michael J. Allegrezza1,
- Melanie R. Rutkowski1,
- Kyle K. Payne1,
- Amelia J. Tesone1,
- Jenny M. Nguyen1,
- Tyler J. Curiel2,3,4,
- Mark G. Cadungog5,
- Sunil Singhal6,
- Evgeniy B. Eruslanov6,
- Paul Zhang7,
- Julia Tchou8,
- Rugang Zhang9 and
- Jose R. Conejo-Garcia1,*
- 1Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania.
- 2The Graduate School of Biomedical Sciences, The University of Texas Health Science Center, San Antonio, Texas.
- 3Department of Medicine, The University of Texas Health Science Center, San Antonio, Texas.
- 4Cancer Therapy and Research Center, The University of Texas Health Science Center, San Antonio, Texas.
- 5Helen F. Graham Cancer Center, Christiana Care Health System, Newark, Delaware.
- 6Division of Thoracic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
- 7Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- 8Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
- 9Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania.
- ↵*Corresponding Author:
Jose R. Conejo-Garcia, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, MRC—Annex 2nd floor 2067D, Tampa, FL 33612. Phone: 802-299-8881; Fax: 215-898-0847; E-mail: Jose.Conejo-Garcia{at}moffitt.org
January 2017
Volume 7, Issue 1
Volume 7, Issue 1
Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
Jump to section
Advertisement